Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2009-10-28FDA Approved: LOTREL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Lotrel (amlodipine besylate and benazepril hydrochloride) by Novartis Pharmaceuticals Corporatio…
-
CLINICAL_TRIALS research · 2009-10-28Clinical Trial Update: Hemodynamic Changes of Upper and Lower Extremities After Spinal Anesthesia [NA]
A clinical trial update examining hemodynamic changes in the upper and lower extremities after spinal anesthesia.
-
CLINICAL_TRIALS trial_result · 2009-10-27Clinical Trial Update: Effects of Acupuncture at ST36 and PC6 on Blood Pressure and Endothelial Dysfunction in Hypertensive Patients [Phase 3]
An acupuncture phase 3 clinical trial evaluates ST36 and PC6 stimulation for blood pressure and endothelial dysfunction in hypertensive pati…
-
FDA approval · 2009-10-22FDA Approved: RAMIPRIL — Supplemental Application (Chartwell RX, LLC.)
FDA approved a supplemental application for RAMIPRIL submitted by Chartwell RX, LLC., indicating approval of a supplemental filing related t…
-
FDA approval · 2009-10-22FDA Approved: RAMIPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for ramipril submitted by Hikma Pharmaceuticals USA Inc. The action confirms continued approval …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-10-22Clinical Trial Update: Telmisartan+HCTZ (Hydrochlorothiazide), Hypertension
Clinical trial update for the fixed-dose combination of telmisartan and hydrochlorothiazide in hypertension; the study is completed and resu…
-
FDA approval · 2009-10-16FDA Approved: MICARDIS — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approves a supplemental application for Micardis (telmisartan) filed by Boehringer Ingelheim Pharmaceuticals, Inc.
-
FDA approval · 2009-10-16FDA Approved: CHLOROTHIAZIDE — Original Application (Fresenius Kabi USA, LLC)
FDA approves Fresenius Kabi USA, LLC's original abbreviated new drug application for chlorothiazide sodium, a thiazide diuretic. The product…
-
CLINICAL_TRIALS trial_result · 2009-10-15Clinical Trial Update: ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation [Phase 3]
Phase 3 trial of irbesartan in patients with acute coronary syndrome without ST-segment elevation has completed.
-
CLINICAL_TRIALS research · 2009-10-15Clinical Trial Update: Fluid Management in the Post-Anesthetic Care Unit (PACU) at Sourasky Medical Center
This entry provides an administrative update on a clinical trial evaluating fluid management in the post-anesthetic care unit at Tel-Aviv So…
-
CLINICAL_TRIALS trial_result · 2009-10-09Clinical Trial Update: Long Term Study Of Amlodipine 10mg With Hypertension For Whom Amlodipine 5mg Is Insufficient [Phase 3]
This document reports results from a Phase 3 long-term trial of amlodipine 10 mg for hypertension in patients not adequately controlled on 5…
-
CLINICAL_TRIALS trial_result · 2009-10-01Clinical Trial Update: Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing [Phase 4]
Phase 4 clinical trial of irbesartan/hydrochlorothiazide completed, evaluating treatment for hypertension.
-
EMA withdrawal · 2009-09-25EMA Withdrawn: Tekturna (aliskiren) — Novartis Europharm Ltd.
Tekturna (aliskiren) has been withdrawn from the European market by Novartis Europharm Ltd.
-
CLINICAL_TRIALS trial_result · 2009-09-23Clinical Trial Update: Anti-Inflammatory Actions of Valsartan in Patients With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 study evaluating anti-inflammatory effects of valsartan in patients with type 2 diabetes mellitus; the trial also involves hypertens…
-
CLINICAL_TRIALS trial_result · 2009-09-23Clinical Trial Update: Blood Pressure Lowering Ability and Safety of an Olmesartan and Amlodipine Based Treatment Regimen in Patients With Stage I and Stage II Hypertension [Phase 3]
This Phase 3 clinical trial update reports the blood pressure lowering efficacy and safety of a treatment regimen combining olmesartan and a…
-
CLINICAL_TRIALS trial_result · 2009-09-21Clinical Trial Update: Feasibility of Integrating Indirect Calorimetry (IC) Technology in Primary Care [NA]
A completed clinical trial examining the feasibility of integrating indirect calorimetry technology in primary care settings for obesity and…
-
FDA approval · 2009-09-17FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's verapamil hydrochloride as an original generic application, adding a new generic calcium channel blocker to the mark…
-
CLINICAL_TRIALS trial_result · 2009-09-15Clinical Trial Update: Irbesartan in Chinese Hypertensive Diabetics With Microalbuminuria [Phase 4]
Phase 4 trial update shows completion of irbesartan study in Chinese hypertensive diabetics with microalbuminuria; results may inform post-m…
-
CLINICAL_TRIALS trial_result · 2009-09-15Clinical Trial Update: Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive Patients [Phase 4]
Phase 4 trial update reporting results for the irbesartan/hydrochlorothiazide combination in achieving target blood pressure for adults with…
-
CLINICAL_TRIALS trial_result · 2009-09-15Clinical Trial Update: Atacand Dose Ranging in Hypertensive Pediatric Subjects 1 Year to Less Than 6 Years of Age [Phase 3]
Phase 3 dose-ranging study of Atacand (candesartan) in hypertensive children aged 1 year to less than 6 years; results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-09-15Clinical Trial Update: An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Patients With Type II Diabetes [Phase 4]
A Phase 4 clinical trial evaluating the blood pressure-lowering efficacy and safety of olmesartan medoxomil in patients with type 2 diabetes…
-
CLINICAL_TRIALS trial_result · 2009-09-15Clinical Trial Update: Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese Population [Phase 4]
A Phase IV trial of the irbesartan/hydrochlorothiazide combination for hypertension in Chinese patients has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-14Clinical Trial Update: Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With Hypertension [Phase 3]
Phase 3 trial evaluating the efficacy and safety of valsartan plus amlodipine versus valsartan alone in patients with hypertension; results …
-
CLINICAL_TRIALS trial_result · 2009-09-11Clinical Trial Update: An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Elderly Patients With Hypertension [Phase 4]
A Phase 4 trial assessed the blood pressure–lowering effect and safety of olmesartan medoxomil in elderly patients with hypertension, with r…
-
CLINICAL_TRIALS trial_result · 2009-09-09Clinical Trial Update: A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components [Phase 4]
A Phase 4 study compares Selomax with its individual components to evaluate differences in efficacy, safety, and tolerability in primary hyp…